Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology
Molecular Imaging Platform Leverages Hyb & Seq Chemistry to Spatially Profile Expression of 1,000+ Genes at Single Cell and Sub-Cell Resolution Across Tissue Samples Available in Technology Access Program in H1-2021 with Commercial Instrument Launch Expected in H2-2022 Details to be Shared During
View HTML
Toggle Summary NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020
SEATTLE --(BUSINESS WIRE)--Nov. 18, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it will host an Investor and Analyst Day on Tuesday, December 1 st .
View HTML
Toggle Summary NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer
Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions SEATTLE --(BUSINESS WIRE)--Nov. 17, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a
View HTML
Toggle Summary NanoString to Present at the Stifel 2020 Virtual Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Nov. 12, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Stifel 2020 Virtual Healthcare Conference .
View HTML
Toggle Summary NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
Presentations Include Data from More than 35 NanoString-Related Abstracts Including 11 Using the GeoMx Digital Spatial Profiler CAR-T Symposium Highlights Characterization of Cellular Therapy Products SEATTLE --(BUSINESS WIRE)--Nov. 11, 2020-- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Third Quarter of 2020
SEATTLE --(BUSINESS WIRE)--Nov. 9, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter of 2020. Third Quarter Financial Highlights Product and service revenue of
View HTML
Toggle Summary NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing
GeoMx Digital Spatial Profiler (DSP) Now Enables Multi-Analyte Spatial Analysis Using Both NGS and nCounter Read-outs SEATTLE --(BUSINESS WIRE)--Nov. 9, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today
View HTML
Toggle Summary NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Nov. 6, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 29 th Annual Credit Suisse Healthcare Conference
View HTML
Toggle Summary NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
SEATTLE --(BUSINESS WIRE)--Oct. 13, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at
View HTML
Toggle Summary NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
SEATTLE --(BUSINESS WIRE)--Oct. 7, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the pricing of an upsized underwritten public offering of 5,000,000 shares of its common stock at a price to the
View HTML